XBiotech (XBIT)

• Market cap: $89.6M
• 1 day: -0.68%
• 5 days: 0.34%
• 1 month: -16.48%
• 3 months: -23.04%
• 6 months: -61.01%
• Year to date: -29.50%
• 1 year: -63.75%
• 5 years: -78.49%
• 10 years: -88.77%
• Sector: Healthcare
• Industry: Biotechnology

About: XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

Employees: 92

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

73% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 11

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

6% more funds holding

Funds holding: 50 [Q3] → 53 (+3) [Q4]

0.45% less ownership

Funds ownership: 15.93% [Q3] → 15.47% (-0.45%) [Q4]

50% less capital invested

Capital invested by funds: $37.5M [Q3] → $18.6M (-$18.9M) [Q4]

94% less call options, than puts

Call options by funds: $6K | Put options by funds: $96K